Incyte Corporation is a global biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for various diseases and conditions. Founded in 1991 by Roy A. Whitfield and Randy W. Scott, the company is headquartered in Wilmington, Delaware. Incyte's research and development efforts are primarily targeted at oncology, inflammation, and autoimmune diseases.